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The al teration of normal dermal fibroblast function that leads 
to the development of hypertrophic scar after thermal injury 
is unknown. To determine functional differences that might 
explain this process, fibroblasts were cultured from biopsies 
of post-thermal injury mature hypertrophic scars an.d pa-
tient-lIlatched normal skin. The mitogenic responses of scar 
cells to fetal bovine serum, epidermal growth factor (EGF), 
platelet-derived growth factor (PDGF), and tumor necrosis 
factor a (TN Fa) were determined and compared to normal 
skin cells. Collagen synthetic rate was also compared in the 
presence and absence of transforming growth factor Pl 
(TG F /31)' Whereas both scar and normal cells respon.ded with 
increased thymidine uptake to serum and cytokmes, the 
stimulation to EGF and serum was significantly lower in scar 
H ypertrophic scar (HTS) formation is the maj~r .fac-tor limiting complete recovery from thermal injury [1]. The events that result in excess scar formation, rather than normal wound healing, have no~ ~een determined. Previous studies of such post-injury 
scars have yielded conflicting data, documenting both increased 
[2,3] and normal [4-6] rates of extracellular matrix synthesis by 
}-ITS tissue. In scleroderma, another disease exhibiting dermal fi-
brosis, the fibroblasts from affected skin are phenotypically differ-
ent from those isolated from uninvolved areas [7 -9] . This alteration 
in phenotype suggests a possible mechanism for disordered healing. 
Previous studies of skin injury and healing have documented 
increased production of a number of cytokines at the site of injury 
[tD - 14]. In vitro studies have shown that prolonged exposure to 
monocyte-derived factors causes a stable alteration in phenotype of 
otherwise normal cells [15]. Hence, prolonged exposure of fibro-
blasts to cytokines at sites of injury and inflammation may represent 
an important influence leading to a population or subpopulations of 
fibroblasts with an altered phenotype. Generation of this phenotype 
would then represent commitment to hypertrophic scar forma.tion 
rather than normal wound healing. This hypothesis was examined 
in patients with HTS after thermal injury. Specifically, the present 
study -was initiated to determine whether fibroblasts from HTS 
tissue are phenotypically different from those derived from normal 
skin. The results suggest that increased matrix deposition and low 
cellularity of HTS lesions are reflected in vitro by the decreased 
responsiveness of HTS-derived cells to mitogenic cytokines and 
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cells. In contrast, synthesis of collagen, but not of non-col-
lagenous proteins, was increased in scar relative to normal 
cells, both basally and when stimulated with low doses of 
TGFPl' Additionally, the fraction of protein synthesized as 
collagen was significantly higher in scar fibroblasts. 
These results suggest that fibroblasts from hypertrophic 
scars demonstrate stable phenotypic differences in cytokine 
responsiveness in comparison to cells from unaffected skin. 
The increased rate of collagen synthesis and decreased re-
sponsiveness to mitogens are consistent with the increased 
extracellular matrix content and decreased cellularity of hy-
pertrophic scars. Key words: hypertrophic scars/dermal fi-
broblasts/TGFPl'] Invest Dermatol 101:875-879, 1993 
serum, but enhanced responsiveness with respect to collagen pro-
duction. 
MATERIALS AND METHODS 
Cells Fibroblasts used for all studies were derived from HTS and normal 
skin (NS), which was excised from patients who developed hypertrophic 
scars after burn injury. The patient population consisted of eight men and 
three women, ranging in age from 7 to 62 years, with a mean age of35 years 
and ~ standard deviation (SO) of 20.4 years. The amount of time post-ther-
mal mJury ranged from 12 to 152 months with a mean (± SO) of 50 ± 51 
months. The extent of burn injury was 43 ± 28% (mean ± SO) of total body 
surface area. Biopsies ranging in size from 20 to 80 cm2 were used as starting 
material. These samples were from both men and women, young and adult 
patients of varying ethnic backgrounds. Skin samples were removed at the 
time of reconstructive surgical procedures (University of Michigan IRE 
91-78). All scars were active, as evidenced by hyperemic appearance, and 
mature, as defined by being present at least 1 year after burn injury. Normal, 
uninjured skin from the same patient was also obtained and used as a source 
of control, NS fibroblasts. 
Each excised skin sample was treated for 1-2 h with 20tLg/ ml gentamicin 
and 2 J.lg/ml amphotericin B. The biopsies were then digested with 0.15% 
t~psin overnight, at room temperature. The following morning the epider-
m~s was mechanically disrupted from the underlying dermis by scraping 
With a scalpel blade and used for other studies. The dennal remnant was 
rinsed with ~hosphate~bulfered saline (PBS), minced into 1-2-mm pieces, 
and further digested With 1 mg/ml filter-sterilized crude collagenase (Sigma 
Chemical Co., St. Louis, MO) for 2 It at room temperature. After nylon 
mesh filtration, the cells were plated at 1-2 X 106 cells/T-75 flask in 
MCDB 110 (Sigma) supplemented with 5% fetal bovine serum (FBS). The 
total cell yield was greater from normal skin than from HTS tissue, reflect-
ing the hypocellular nature of the latter. The MCDB 110 media were 
modified for use in a 5% CO2 incubator by the addition of 26 mM Na2C03 
and the pH was adjusted to 7.1. The cells were grown to confluence at 
passage 0 and were essentially 100% fibroblasts by visual inspection. Some 
al~quots of cells were then stored under liquid N2 in media supplemented 
With 20% FBS and 10% dimethylsulfoxide (DMSO) until required for 
experimentation. The remainder of cells were either used immediately in 
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experiments or passaged after brief trypsinization using a one-to-
three split ratio. All studies reported here were performed only on 
cells at passages :s 3. 
Mitogenesis Assay Mitogenic response to serum and cytokines was de-
termined essentially as previously described (16]. Briefly, 10' fibroblasts in 
MCDB 110 containing 5% FBS were plated into each well of a 96-well 
microtiter plate. After overnight incubation, the media were removed, the 
cells washed, and the media replaced with MCDB 110 containing 0.4% 
FBS. After 24 h, the ce lls were exposed to the indicated doses of either FBS, 
platelet-derived growth factor (PDGF, from human platelets, specific activ-
ity 500 units/Jig; Upstate Biotechnology, Lake Placid, NY), epidermal 
growth factor (EGF, from mouse submaxillary gland; Sigma), or tumor 
necrosis factor a (TN Fa, specific activity.> 2 X 106 units/ml; R&D Sys-
tems, Minneapolis, MN) for another 24 h. During the last 6 h of incubation, 
the ce lls in each wel l were pulsed with 1.0 f.1Ci of lH-thymidine (specific 
activity 60 Ci/mmol; ICN Biomedicals, Irvine, CAl. The cells were then 
trypsinized and transferred onto glass-fiber filters using an automated har-
vester (Brandel, Gaithersburg, MD). After washing, the filters were counted 
for radioactivity and data were expressed as dpm incorporated per well. 
Collagen Synthesis Assay Protein synthesis was measured as previously 
described (17]. Briefly, 105 cells were plated into each well of a 12-well tissue 
culture plate (22 mm in diameter) and allowed to adhere overnight. The 
media were then removed, and replaced with serum-free media supple-
mented with 2 mg/ml BSA (Sigma). After 24 h incubation, the cells were 
treated with the indicated concentrations of transforming growth factor PI 
(TGFP1' porcine platelet-derived; R&D Systems, Mirmeapolis, MN) for 
48 h in media supplemented with 50 f.1g/ml sodium ascorbate and 2 mg/ml 
bovine serum albumin (BSA). During the last 6 h of incubation, the cells 
were pulsed with 5 f.1 Ci/ml 3H-proline (specific activity 93 Ci/mmol, 
Amersham Radiochemicals, Arlington Heights, IL) in the presence of P-
aminoproprionitrile (BO f.1g/ml). The media and one wash were then col-
lected and analyzed for radioactivity in collagenous and noncollagenous 
proteins, as defined by susceptibility to degradation by purified bacterial 
collagenase [l B]. Under these conditions> BO% of the newly synthesi.zed 
collagenous proteins are secreted into the media (data not shown). The cell 
layer in each well was harvested by trypsinization and cell number deter-
mined using a Coulter counter. Protein synthetic rates were expressed as 
dpm incorporated by 105 cells during the 6-h pulse. The fraction of protein 
synthesis devoted to collagen or percent collagenous protein synthesis was 
c'alculated as previously described after correcting for the lower average 
content of proline in non-collagenous proteins (19]. 
Data Analysis Statistical comparisons of mitogenic and protein synthetic 
responses were performed on mean values for each cytokine dosage using 
analysis of variance (AN OVA). When significant differences were found , 
the method ofTukey (SAS Institute, Inc., Cary, NC) Was used for individual 
comparisons. Where necessary to meet the normal distribution requirement 
for the use of ANOVA, the data were log-transformed prior to application of 
ANOVA and Tukey's Studentized range test. 
RESULTS 
Mitogenic Responsiveness to Serum and Cytokines There 
were no significant differences in basal (in 0.4% FBS) rates of thy-
midine incorporation between HTS and NS fibrobl asts from the 
same subject. As there is some variation in absolute rates of thymi-
dine uptake from day to day, and significant heterogeneity in the 
patient population, all values were normalized to the dpm taken up 
by their own respective control cells exposed only to 0.4% FBS. 
When expressed in this manner, the mitogenic response ofHTS 
fibroblasts was not significantly different from NS cells at doses of 
FBS < 2.5% (Fig 1). At doses ~ 2.5% FBS, the NS cells were sig-
nificantly more responsive compared to HTS cells, except for the 
highest dose (20%) tested, when the differences disappear (Fig 1). 
Peak stimulation of thymidine uptake in both HTS and NS cells 
occurred at 2 .5-5% FBS, a standard result for primary human der-
mal fibroblast cultures in this laboratory. Decreasing stimulation is 
seen with higher levels of serum supplementation. At 20% FBS, 
HTS fibroblasts showed no increased uptake above baseline. The 
maximal difference between HTS and NS fibrobl asts occurred at 
2.5% FBS, when the HTS response was approximatel y 64% of 
normal. 
EGF is present in platelets [20] and hence represents one of the 
mi togens present in serum. To evaluate whether it could be one of 
the mitogens responsible for the distinction observed between HTS 
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and NS in their response to FBS, the effects of pure authentic EGF 
were examined. The responses of HTS and NS fibroblas ts to EGF 
are shown in Fig 2. There was a significant i~crease in thymidine 
uptake by both HTS and NS cells when stimulated with EGF 
including that at the lowest dose tested, namely 0.5 ng/ml. Th~ 
shapes of the dose-response curves for both HTS and NS cells to this 
mitogen were similar, but the magnitudes of the responses were 
significantly greater in NS cells at all doses ofEGF indicated in Fig 
2. As a result of EGF stimulation, incorporation averaged 700% of 
control for NS and 420% of control for HTS. The maximal EGF-
induced mitogenic stimulation is approximately twice as great for 
NS as for HTS fibrobl asts, which was comparable to that seen at the 
peak of FBS (2.5% dose) stimulation. EGF doses greater than 8 
ng/ml failed to cause any further increase in the mitogenic re-
sponses of both HTS and NS cells (data not shown). 
PDGF is a cytokine with well-known mitogenic properties, and 
has been implicated in the pathogenesis of fibrosis [21,22]. It is also 
present in platelets [20] and thus represents another important mi-
togenic component of serum. To determine whether PDGF also 
plays a role in the ability of serum to discriminate between HTS and 
NS cells, the effects of authentic PDGF were also studied. The 
mitogenic responses to varying doses of PDGF show an increase in 
thymidine uptake with increasing concentrations ofPDGF in both 
NS and HTS. In contrast to the EGF dose-response curves how -
ever, the responsiveness ofHTS was not significantly differe~t from 
that ofNS cells at all doses ofPDGF studied (data not shown). This 
would suggest that the discriminating properties of serum were not 
due to its PDGF component. 
~NFa is primarily produced by. macr~p~lages and monocytes, 
w l1lch are known to be prese nt at sites of ll1Jury and inflammation 
[23 ,24] . It is known to be important in fibrotic responses in other 
organ systems, including the skin [25]. It is known to have growth-
promoting properties i/1 vitro and thus represents another type or 
class of growth factor [26]. Therefore the effects of this cytokine on 
fibrobl ast proliferation were evaluated to see whether this cyto1cine 
could also distinguish the HTS from NS cells. The results of TN Fa 
stimul ation show that the dose-response curves were similar in 
shape to those for EGF, but the magnitudes of the responses by HTS 
cells to TNFa were not significantly different from those for NS 
cells at all doses (0-10 ng/ml) studied (data not shown). The HTS 
cell responses at the indicated doses of TN Fa ranged from 70 - 90% 
of those fo r NS cells. This suggests that at the site of injury, in-
creased production of TNFa is unlikely to affect the selection of 
fibroblast subpopulation(s) with the HTS phenotype. 
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Figure 1. Mitogenic response to FBS. HTS and NS fibroblasts were com-
pared for 3H-thymidine uptake after stimulation with the indicated doses of 
FBS as described in Materials alld Methods. The mitogenic response of NS 
fibroblasts was significantly greater than that of HTS cells only at FBS 
concentrations of2.5, 5, and 10% (p < 0.05) . Data represent the mean dpm 
(±SEM, n = 11) taken up per well after expression as a percentage of the 
mean dpm taken up by the respective control cells exposed only to 0.4% 
FBS. Baseline incorporation by these control ce lls ranged from 1000 to 
2500 dpm per well. 
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Collagen Synthetic Phenotype Hypertrophic scars are charac-
terized by the increased content of the extracellular matrix, includ-
ing collagen [27]. Although the data are conflicting with regard to 
the demonstration of increased collagen synthesis by scar tissue, the 
end result of increased collagen deposition is clear [28]. This in-
creased collagen could be the result of increased synthesis, and is 
perhaps connected with decreased breakdown. To examine 
whether such an increased rate of collagen synthesis could be a 
phenotypic characteristic of the HTS . c~lls, the basal and 
TGFPt-stimulated rates of collagen synthesIs m NS and HTS cells 
were measured. The basal or non-stimulated rate of collagen syn-
thesis 'Was significantly greater in HTS fibroblasts compared to their 
matched NS cells. In addition, when these cells were stimulated 
with 0.5 and 1.0 ngjml ofTGFPI> the collagen synthetic response 
of HTS fibroblasts remained significantly greater (Fig 3). When a 
higher dose of TGFPI (2 ngjml) was used, the NS cells a'lmost 
doubled their collagen production, whereas the responses in ~TS 
cells appear to show no further significant increases or may declme, 
compared to those at 0.5 and 1.0 ngjml TGFPI' Consequently, the 
difference in collagen synthesis between HTS and NS cells became 
insignificant at 2 ngjml TGF PI' In contrast to collagen syn~he~ls, 
the synthesis of secreted noncollagenous proteins was not slgmfi-
candy different between HTS and NS cells, both basally and in the 
presence of the same doses ofTGFPI (data not shown). As a c.ons.e-
quence the percentage of protein synthesized as collagen was slgmf-
icantly greater in HTS (25.6 ± 1.1) versus NS cells (21.4 ± 1.3) 
(p < 0.02). 
DISCUSSION 
Because basic understanding of the pathogenesis of HTS is l~c~in~, 
the present study attempts to document potential abnormahttes 111 
the fibroblasts contained within these lesions. The data show that 
fibroblasts isolated from resected HTS lesions have distinguishing 
phenotypic features from those isolated from normal unaffected 
skin of the same individual. Although both HTS and NS cells re-
sponded to known growth factors, the HTS cells were significantly 
less responsive to selected doses of serum and EGF. However, t~e 
mitogenic response to another growth factor normally present 10 
serum, nazn.ely PDGF, was not significantly different between the 
cwo cell populations. This suggests that the differential response t.o 
serum may be primarily due to the EGF present in serum. TNFa.ls 
another cytokine known to be present in injured and mfla,xned ~IS­
sue, and has been reported to also stimulate cell prohferat~on 
[26,29]. As with PDGF, it was also unsuccessful in distriminatlllg 
HTS from NS cells. The basis for this selective effect of EGF IS 
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figure 2. Mitogenic response to EGF. EGF dose-respon~e cUr:'es for 3H_ 
rhymidine uptake in HTS and NS cells are shown. The nutogel1lc response 
pfHTS fibroblasts was significantly decreased compared to NS cells. at all 
~dicated concentrations of EGF (p < 0.05). Data were expressed as III the 
legend to Fig 1. 
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Figure 3. Collagen synthesis. Collagen production by HTS and NS cells 
was measured as described in Materials and Methods, in the absence and pres-
ence of the indicated doses of TGFp,. Significant differences in collagen 
production between HTS and NS fibroblasts were present basally {no added 
TGFP,} and atO.5 and 1ng/ml TGFp, . The responses of these two cell types 
were not significantly different at 2 ng/ml TGFp,. Data were expressed as 
dpm incorporated into collagenase-sensitive proteins per 105 cells, and rep-
resented the mean values ± SEM (n = 11). 
unclear, but may be related to decreased expression ofEGF receptors 
in the HTS cells andj or diminished signal transduction in the HTS 
cells. This diminished responsiveness to a common growth factor 
may be important in accounting for the decreased cellularity of the 
mature HTS lesion. Further studies are necessary to uncover the 
mechanistic basis for this observation. 
In contrast to mitogenic responsiveness, the HTS cells were upre-
gulated with respect to collagen production when compared to NS 
cells. This elevated level of collagen production was observed both 
in the absence of added exogenous stimuli and in the presence of,s; 1 
ngjml ofTGFPh with the difference dissipating at higher doses due 
to the increased production by NS cells. The basis for this elevated 
rate of collagen production is also unknown, but may be related to 
autocrine stimulation by a heightened rate of endogenous TGFPI 
gene expression by the HTS cells themselves. This relatively stable 
phenotypic alteration is consistent with the observation of increased 
matrix deposition in HTS lesions, thus suggesting a role for this 
property in the genesis of such lesions. 
Because the changes in fibroblast phenotype occurred in cells 
derived from lesions 1-12 years after burn injury, it is unlikely that 
these findings reflect the direct activity of mediators released into 
the healing burn wound. Moreover, many of these scars had a stable 
appearance during the previous months, suggesting that the acute 
phase of wound healing was complete and that direct effects of 
mediators released during this period would also have waned. Al-
though it is possible that a long-standing mediator release into the 
local wound environment would result in the described changes in 
cell function, this possibility is unlikely because the phenotype was 
maintained in culture. The cells used for these studies were at pas-
sages 2- 3, or after 3 - 5 population doublings away from primary 
culture with a 1 : 3 split ratio at each passage. After this number of 
cell divisions, the acute responses to a local mediator would be 
expected to decrease, and basal cell responses to be expressed. 
The altered phenotype of HTS cells may be a result of selection 
and/or prolonged exposure to mediators present in injured skin. 
Local wound environment may encourage or diminish the growth 
of specific clones of fibroblasts, thus selecting for or against one or 
more subpopulations, thus yielding cells with the final phenotype 
observed in this study. Alternatively, specific events, such as cyto-
kine release during burn wound healing, might permanently alter 
cellular responses, resulting in cell populations with a different phe-
notype. The latter mechanism, however, has not been documented, 
and furthermore there is no evidence that these cells are trans-
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formed. On the other hand, the heterogeneity of fibroblast popula-
tions has been documented in human skin [30 -32) and in other 
tissues [33-37] . Populations found in biopsies from kidneys with 
interstitial fibrosis are different, displaying an increased cellularity 
in association with a phenotype with higher cell-replication rates 
[34]. Similar findings have been found in rat lung and normal der-
mal fibroblast populations, which differ in cell surface receptors, 
collagen synthetic potential, as well as in responsiveness to prosta-
glandin E2 [36,37] . 
The heterogeneity of human dermal fibrobl asts has been found to 
be related, in part, to anatomic location within the dermis. Cells 
from the superficial (papillary) dermis exhibit greater proliferative 
capacity than those derived from reticular dennis [30] . Whereas 
collagen synthetic response is not different between these tissue 
regions, type I pC collagen was increased in medium from cultured 
reticular fibroblasts. This finding may be relevant to the clinical 
finding that HTS is more common after deeper burn injury and may 
lead to the specific findings of this study. After deep burn injury the 
healing wound is populated by cells with an intrinsic potential to 
synthesize more collagen [38]. If the healing wound is populated by 
such cells the normal matrix homeostasis would be disturbed, and 
more matrix protein would result. 
Fibroblasts cultured from patients with scleroderma, a systemic 
disease associated with skin fibrosis, display an increased synthesis of 
matrix proteins and altered cytokine responses [7 - 9]. This pheno-
type could be a result of prolonged exposure to monocyte-derived 
factors, which have been shown to persist even after removal of the 
cells from the influence of these factors [15]. The implication is that 
changes in the dermal fibroblast phenotype may be cytokine driven 
by tissue monocytes. Studies of pulmonary fibrosis have docu-
mented increased lung fibroblast collagen synthesis by cells isolated 
from fibrotic lungs. Experimentally, this has been related to stimu-
lated endothelial cell expression of TGFPI [39,40]' Dermal cells, 
including keratinocytes, are known to produce TGFp [41,42]. The 
phenotype of HTS fibroblasts is similar to that seen after TGFp 
exposure, suggesting a role for this cytokine in the HTS alteration 
bf the dermal fibroblast phenotype. This conclusion is supported by 
the loss of differences in collagen synthesis at the higher TGFp dose. 
Studies are currently in progress to determine the role of TGFp in 
inducing the documented changes in cell phenotype. A variety of 
other stimuli may also cause increased local deposition of collagen. 
For instance, early scar formation may subsequently decrease the 
relative vascularity of the burn wound. Measurements of the tissue 
p02 in fibrotic skin show significant decreases compared to normal 
skin [43]. Because hypoxia stimulates TGF P synthesis [44,45], this 
may result in increased collagen synthesis and persistence of fibrosis. 
Cell clones able to tolerate this environment would persist, result-
ing in the selected phenotype reported in this study. 
Although these data document an in vitro cellular difference be-
tween HTS and NS cells, the functional or pathophysiologic signif-
icance of this finding is unclear. Studies of phenotypic differences in 
cells isolated from serial biopsies along with clinical and functional 
correlation will be necessary to accurately determine their signifi-
cance. 
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